Is there added value of the hepatobiliary phase of MRI with hepatobiliary contrast agents for hepatocellular carcinoma diagnosis? A meta-analysis
We found no statistically significant differences in sensitivities between studies with and without the HBP (<i>p</i> = 0.1651).
Authors
- Karolina Markiet (ORCID: https://orcid.org/0000-0002-1984-2959)
- Joanna Pieńkowska (ORCID: https://orcid.org/0000-0002-7087-9888)
- Dorota Rybczyńska (ORCID: https://orcid.org/0000-0002-6868-3448)
- Andrzej F. Frydrychowski
Institutions
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Polish Journal of Radiology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.5114/pjr/189614
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00